Icon

GRIS-PEG (nda050475)- (125MG,250MG)

GRISEOFULVIN, ULTRAMICROSIZE BAUSCH
125MG,250MG
No No
Expired Expired
None None
None No
Gris-PEG® (griseofulvin ultramicrosize) is indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis,Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audouini, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum.
6 0 5
Total Other Developers None
Drugs with Suitability Yes
125MG ** ** - - 3
250MG ** ** - 1 3
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ** ********* *************** *******, ***. *********** ** ******* *****, *** ***** ******, *******, *** **** (**) *****, ****** ****** (***) ***
****** ********** **** *** ********** ************, *** *********** **** ******** *****, ********, ************ (**) *****, ****** ****** (***) ***
****** ****** *** ******* ******* *********** *-**, **, ***, **, **, **, **, ** & *-**, ****, ******* ****** ***** *****, ******, *****, ***** & *** ******, ***** (***) ***
****** ******** *** ***************, ***. *********** *** **** ****** ****, ********, ********* (**) *****, ****** ****** (***) ***
****** ****** *** ******* ******* *********** *-**, **, ***, **, **, **, **, ** & *-**, ****, ******* ****** ***** *****, ******, *****, ***** & *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.